Prestige Consumer Healthcare Inc. (PBH) — Fair Value Analysis
Base-case fair value (P50): $49.27 · Current price: $46.33 · Verdict: Fairly Valued
The Verdict on PBH
PRESTIGE CONSUMER HEALTHCARE INC (PBH) is currently assessed as Fairly Valued according to our Monte Carlo simulations. With a current price of $46.33, our sophisticated modeling points to a median fair value (P50) of $49.27, indicating a potential upside of +6.3%. This analysis suggests that PBH is neither significantly overvalued nor undervalued at its present trading level, based on thousands of forward-looking scenarios. The Monte Carlo framework accounts for a broad spectrum of fundamental outcomes, establishing this median value as the most probable fair valuation, consistent with the company's average quality tier.
How PBH stacks up against peers
PBH's operational and financial health registers in the average quality tier when benchmarked against its sector peers. This assessment of an average quality tier plays a role in the stock being deemed Fairly Valued, rather than experiencing an extreme overvaluation or undervaluation. The current price of $46.33 thus reflects a market perception that is largely consistent with a company exhibiting typical sector strengths and weaknesses. This positioning contributes to the identified +6.3% gap between the current price and the median fair value of $49.27, suggesting a balanced market view.
What this means for investors
For investors considering PRESTIGE CONSUMER HEALTHCARE INC, the Fairly Valued verdict implies a balanced risk/reward profile at the current price of $46.33. Our Monte Carlo simulation suggests a median fair value of $49.27, representing a +6.3% potential upside from current levels. While this doesn't signal deep value, the modest upside indicates that the market currently prices PBH in line with its underlying fundamentals and average quality tier. Investors seeking significant alpha might find this less compelling without a deeper dive into the full distribution of outcomes. FairCurve users can access the comprehensive bear and bull case distributions. To see the full bear/bull distribution and track PBH's fair value as new fundamentals are released, sign up for a free FairCurve account today.
Frequently Asked Questions
Is PBH overvalued or undervalued right now?
PRESTIGE CONSUMER HEALTHCARE INC (PBH) is assessed as Fairly Valued. With a current price of $46.33 and a median fair value (P50) of $49.27, the stock shows a potential upside of +6.3% to its fair value.
What is the bear case and bull case for PBH?
The full Monte Carlo distribution, including the bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account.
How does FairCurve calculate PBH's fair value?
FairCurve calculates PBH's fair value using Monte Carlo simulations, running thousands of forward-looking scenarios to determine a comprehensive valuation range.
How can I track PBH's fair value as it changes?
You can add PBH to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation when new earnings or significant fundamental news are released.